Glysennid



Indications and Reactions:

Role Indications Reactions
Primary
Constipation 32.8%
Gastric Cancer 32.8%
Cancer Pain 24.6%
Depression 6.6%
Atrial Fibrillation 1.6%
Hepatic Neoplasm Malignant 1.6%
Stomatitis 20.0%
Rash 12.0%
Blood Potassium Decreased 8.0%
Hypokalaemia 8.0%
Lung Disorder 8.0%
Ureteric Haemorrhage 8.0%
Abdominal Pain 4.0%
Dehydration 4.0%
Hyponatraemia 4.0%
Ileus 4.0%
Infertility 4.0%
International Normalised Ratio Decreased 4.0%
Lymphocyte Stimulation Test Positive 4.0%
Mental Impairment 4.0%
Pancreatic Enzymes Increased 4.0%
Secondary
Parkinson's Disease 27.3%
Drug Use For Unknown Indication 14.1%
Constipation 10.2%
Cardiac Failure 7.8%
Anxiety 6.3%
Neurogenic Bladder 5.5%
Gastric Ulcer 3.1%
Gastritis 3.1%
Parkinsonism 3.1%
Anxiety Disorder 2.3%
Cancer Pain 2.3%
Hyperlipidaemia 2.3%
Arrhythmia 1.6%
Delusion 1.6%
Dyspepsia 1.6%
Haemorrhoids 1.6%
Obesity 1.6%
Pneumonia 1.6%
Prophylaxis 1.6%
Reflux Oesophagitis 1.6%
Erythromelalgia 22.2%
Liver Disorder 11.1%
Rash 11.1%
Toxic Epidermal Necrolysis 11.1%
Weight Decreased 11.1%
Withdrawal Syndrome 11.1%
Hepatic Function Abnormal 5.6%
Lymphocyte Stimulation Test Positive 5.6%
Overdose 5.6%
Swelling 5.6%
Concomitant
Constipation 16.9%
Drug Use For Unknown Indication 15.2%
Hypertension 11.1%
Prophylaxis 7.6%
Rheumatoid Arthritis 7.6%
Insomnia 6.5%
Diabetes Mellitus 4.9%
Depression 3.3%
Gastric Ulcer 2.9%
Gastritis 2.7%
Cancer Pain 2.5%
Osteoporosis 2.2%
Angina Pectoris 2.2%
Hyperlipidaemia 2.2%
Herpes Zoster 2.1%
Renal Cell Carcinoma 2.1%
Schizophrenia 2.1%
Pleural Mesothelioma Malignant 2.0%
Parkinson's Disease 1.9%
Gastritis Prophylaxis 1.9%
White Blood Cell Count Decreased 17.6%
Interstitial Lung Disease 8.8%
Shock 6.1%
Ileus 5.4%
Liver Disorder 5.4%
Vomiting 5.4%
Somnolence 4.7%
Cerebral Haemorrhage 4.1%
Pyrexia 4.1%
Renal Failure 4.1%
Stevens-johnson Syndrome 4.1%
White Blood Cell Count Increased 4.1%
Hypoglycaemia 3.4%
Pneumonia 3.4%
Pneumonia Aspiration 3.4%
Pneumonia Bacterial 3.4%
Suicidal Ideation 3.4%
Thrombocytopenia 3.4%
Urinary Tract Infection 3.4%
Hepatic Function Abnormal 2.7%